Classification of multiple sclerosis patients by latent class analysis of magnetic resonance imaging characteristics

Abstract

Background Disease heterogeneity is a major issue in multiple sclerosis (MS). Classification of MS patients is usually based on clinical characteristics. More recently, a pathological classification has been presented. While clinical subtypes differ by magnetic resonance imaging (MRI) signature on a group level, a classification of individual MS patients based purely on MRI characteristics has not been presented so far.

Objectives To investigate whether a restricted classification of MS patients can be made based on a combination of quantitative and qualitative MRI characteristics and to test whether the resulting subgroups are associated with clinical and laboratory characteristics.

Methods MRI examinations of the brain and spinal cord of 50 patients were scored for 21 quantitative and qualitative characteristics. Using latent class analysis, subgroups were identified, for whom disease characteristics and laboratory measures were compared.

Results Latent class analysis revealed two subgroups that mainly differed in the extent of lesion confluency and MRI correlates of neuronal loss in the brain. Demographics and disease characteristics were comparable except for cognitive deficits. No correlations with laboratory measures were found.

Conclusions Latent class analysis offers a feasible approach for classifying subgroups of MS patients based on the presence of MRI characteristics. The reproducibility, longitudinal evolution and further clinical or prognostic relevance of the observed classification will have to be explored in a larger and independent sample of patients.

Keywords

heterogeneity latent class analysis MRI multiple sclerosis

Get full access to this article

View all access options for this article.

References

Noseworthy JH , Lucchinetti C , Rodriguez M , Weinshenker BG. Multiple sclerosis . N Engl J Med 2000; 343: 938-952 .

Lublin FD , Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis . Neurology 1996; 46: 907-911 .

Lucchinetti C , Bruck W , Parisi J , Scheithauer B , Rodriguez M , Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination . Ann Neurol 2000; 47: 707-717 .

Lassmann H , Reindl M , Rauschka H , Berger J , Aboul-Enein F , Berger T et al. A new paraclinical CSF marker for hypoxia-like tissue damage in multiple sclerosis lesions . Brain 2003; 126: 1347-1357 .

Lucchinetti CF , Altintas A , Wegner C , Menk S , Lassmann H , Bitsch A et al. Magnetic resonance imaging correlates of multiple sclerosis pathologic sub-types . Ann Neurol 2003; 56: S37-S37 .

Bitsch A , Bruck W. MRI-pathological correlates in MS . Int MSJ 2000; 8: 89-103 .

Van Waesberghe JH , Kamphorst W , De Groot CJ , van Walderveen MA , Castelijns JA , Ravid R et al. Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability . Ann Neurol 1999; 46: 747-754 .

Miller DH , Grossman RI , Reingold SC , McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis . Brain 1998; 121: 3-24 .

Bruck W , Neubert K , Berger T , Weber JR. Clinical, radiological, immunological and pathological findings in inflammatory CNS demyelination - possible markers for an antibody-mediated process . Mult Scler 2001; 7: 173-177 .

10.

Morgen K , Jeffries NO , Stone R , Martin R , Richert ND , Frank JA et al. Ring-enhancement in multiple sclerosis: marker of disease severity . Mult Scler 2001; 7: 167-171 .

11.

Truyen L , Van Waesberghe JH , van Walderveen MA , van Oosten BW , Polman CH , Hommes OR et al. Accumulation of hypointense lesions (‘black holes’) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis . Neurology 1996; 47: 1469-1476 .

12.

Miller DH , Barkhof F , Frank JA , Parker GJ , Thompson AJ. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance . Brain 2002; 125: 1676-1695 .

13.

Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited . Curr Opin Neurol 2002; 15: 239-245 .

14.

Nijeholt GJ , van Walderveen MA , Castelijns JA , Van Waesberghe JH , Polman C , Scheltens P et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms . Brain 1998; 121: 687-697 .

15.

Thompson AJ , Kermode AG , MacManus DG , Kendall BE , Kingsley DP , Moseley IF et al. Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study . BMJ 1990; 300: 631-634 .

16.

Lee MA , Smith S , Palace J , Narayanan S , Silver N , Minicucci L et al.

Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?

Brain 1999; 122: 1261-1270 .

17.

Van Waesberghe JH , van Walderveen MA , Caste-lijns JA , Scheltens P , Nijeholt GJ , Polman CH et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR . AJNR Am J Neuroradiol 1998; 19: 675-683 .

18.

Eikelenboom MJ , Petzold A , Lazeron RH , Silber E , Sharief M , Thompson EJ et al. Multiple sclerosis: neurofilament light chain antibodies are correlated to cerebral atrophy . Neurology 2003; 60: 219-223 .

19.

Rao SM , Leo GJ , Haughton VM , Aubin-Faubert P , Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis . Neurology 1989; 39: 161-166 .

20.

Boringa JB , Lazeron RH , Reuling IE , Ader HJ , Pfennings L , Lindeboom J et al. The Brief Repeatable Battery of Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practice . Mult Scler 2001; 7: 263-267 .

21.

Petzold A , Eikelenboom MJ , Gveric D , Keir G , Chapman M , Lazeron RH et al. Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations . Brain 2002; 125: 1462-1473 .

22.

Celeux G , Hurn M , Robert CP. Computational and inferential difficulties with mixture posterior distributions . J Am Stat Assoc 2000; 95: 957-970 .

23.

Diebolt J , Robert CP. Estimation of finite mixture distributions through Bayesian sampling . J R Stat Soc Ser B 1994; 56: 363-375 .

24.

Camp SJ , Stevenson VL , Thompson AJ , Miller DH , Borras C , Auriacombe S et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates . Brain 1999; 122: 1341-1348 .

25.

Rovaris M , Filippi M , Falautano M , Minicucci L , Rocca MA , Martinelli V et al. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis . Neurology 1998; 50: 1601-1608 .